Avidity Partners Management LP Regenxbio Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 532,000 shares of RGNX stock, worth $3.88 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
532,000
Previous 1,132,564
53.03%
Holding current value
$3.88 Million
Previous $11.9 Million
65.39%
% of portfolio
0.46%
Previous 0.73%
Shares
3 transactions
Others Institutions Holding RGNX
# of Institutions
190Shares Held
44.2MCall Options Held
159KPut Options Held
40.7K-
Black Rock Inc. New York, NY8.61MShares$62.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$35 Million2.9% of portfolio
-
Jpmorgan Chase & CO New York, NY4.14MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$21.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.19MShares$16 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $316M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...